Important objectives in the development of stratified medicines include the identification and confirmation of subgroups of patients with a beneficial treatment effect and a positive benefit-risk balance. We report the results of literature review on methodological approaches to the design and analysis clinical trials investigating a potential heterogeneity of treatment effects across subgroups. The identified approaches are classified based on certain characteristics of the proposed trial designs and analysis methods. We distinguish between exploratory and confirmatory subgroup analysis, frequentist, Bayesian and decision-theoretic approaches and, lastly, fixed-sample, group-sequential and adaptive designs and illustrate the available tria...
Recent developments in genomics and proteomics enable the discovery of biomarkers that allow identif...
AbstractLarge randomized phase III prospective studies continue to redefine the standard of therapy ...
OBJECTIVE: To investigate the planning of subgroup analyses in protocols of randomised controlled tr...
Important objectives in the development of stratified medicines include the identification and confi...
Subgroup analyses (e.g., baseline information, biomarkers measurements) are commonly encountered and...
The increasing awareness of treatment effect heterogeneity has motivated flexible designs of confirm...
A critical part of clinical trials in drug development is the analysis of treatment efficacy in pati...
Contains fulltext : 171557.pdf (publisher's version ) (Open Access)BACKGROUND: It ...
Large randomized controlled clinical trials are the gold standard to evaluate and compare the effect...
Individualized or personalized medicine has become a buzzword in the academic as well as public deba...
Background: It is well recognized that treatment effects may not be homogeneous across the study pop...
Biomarker-guided clinical trial designs, which focus on testing the effectiveness of a biomarker-gui...
textIn randomized clinical trials, medical researchers are interested to determine the effectiveness...
Recent developments in genomics and proteomics enable the discovery of biomarkers that allow identif...
Thesis (Ph.D.)--University of Washington, 2016-08Our increased understanding of genomics and related...
Recent developments in genomics and proteomics enable the discovery of biomarkers that allow identif...
AbstractLarge randomized phase III prospective studies continue to redefine the standard of therapy ...
OBJECTIVE: To investigate the planning of subgroup analyses in protocols of randomised controlled tr...
Important objectives in the development of stratified medicines include the identification and confi...
Subgroup analyses (e.g., baseline information, biomarkers measurements) are commonly encountered and...
The increasing awareness of treatment effect heterogeneity has motivated flexible designs of confirm...
A critical part of clinical trials in drug development is the analysis of treatment efficacy in pati...
Contains fulltext : 171557.pdf (publisher's version ) (Open Access)BACKGROUND: It ...
Large randomized controlled clinical trials are the gold standard to evaluate and compare the effect...
Individualized or personalized medicine has become a buzzword in the academic as well as public deba...
Background: It is well recognized that treatment effects may not be homogeneous across the study pop...
Biomarker-guided clinical trial designs, which focus on testing the effectiveness of a biomarker-gui...
textIn randomized clinical trials, medical researchers are interested to determine the effectiveness...
Recent developments in genomics and proteomics enable the discovery of biomarkers that allow identif...
Thesis (Ph.D.)--University of Washington, 2016-08Our increased understanding of genomics and related...
Recent developments in genomics and proteomics enable the discovery of biomarkers that allow identif...
AbstractLarge randomized phase III prospective studies continue to redefine the standard of therapy ...
OBJECTIVE: To investigate the planning of subgroup analyses in protocols of randomised controlled tr...